Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

  title={Vitamin D signalling pathways in cancer: potential for anticancer therapeutics},
  author={Kristin K. Deeb and D. Trump and C. Johnson},
  journal={Nature Reviews Cancer},
  • Kristin K. Deeb, D. Trump, C. Johnson
  • Published 2007
  • Medicine
  • Nature Reviews Cancer
  • Epidemiological studies indicate that vitamin D insufficiency could have an aetiological role in various human cancers. Preclinical research indicates that the active metabolite of vitamin D, 1α,25(OH)2D3, also known as calcitriol, or vitamin D analogues might have potential as anticancer agents because their administration has antiproliferative effects, can activate apoptotic pathways and inhibit angiogenesis. In addition, 1α,25(OH)2D3 potentiates the anticancer effects of many cytotoxic and… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    Paper Mentions

    The purpose of this study is to determine the safety and usefulness of oral Vitamin D supplementation in subjects with in situ carcinoma. More specifically, this study is being… Expand
    ConditionsBreast Cancer
    Molecular Aspects of Vitamin D Anticancer Activity
    • 40
    • Highly Influenced
    The role of vitamin D in cancer prevention and treatment.
    • 43
    • PDF
    Mechanistic Insights of Vitamin D Anticancer Effects.
    • 34
    Why vitamin D for cancer patients?
    • 10
    • PDF
    Vitamin D: Metabolism, molecular mechanisms, and mutations to malignancies
    • 19
    New insights into vitamin D anticancer properties: focus on miRNA modulation
    • 18
    • Highly Influenced
    The Role of Vitamin D and Vitamin D Receptors in Colon Cancer
    • 17
    Vitamin D metabolism and action in the prostate: Implications for health and disease
    • 44


    Publications referenced by this paper.
    Antiproliferative action of vitamin D.
    • 138
    • PDF
    Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue
    • 180
    • PDF